Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/00 → 10/31/04 |
Funding
- Eli Lilly and Company: $12,186.00
A Phase III Trial of ALIMTA vs Docetaxel in Patients with Locally Advanced or Metastasic Non-Small Lung Cancer (NSCLC) who were previously treated with Chemotherapy
- Arnold, Susanne (PI)